Roundup / Glyphosate Lawsuit — Roundup cancer lawsuit

Roundup is a widely used weedkiller originally made by Monsanto and now owned by Bayer. Its active ingredient, glyphosate, has been linked to non-Hodgkin's lymphoma, a type of blood cancer. Tens of thousands of users have filed lawsuits claiming the manufacturer knew about the cancer risk and failed to warn.

The International Agency for Research on Cancer classified glyphosate as probably carcinogenic to humans in 2015. Bayer disputes that conclusion and points to other regulatory reviews. Litigation across federal and state courts has continued for nearly a decade.

As of 2026, Bayer announced a proposed $7.25 billion settlement to resolve current and future Roundup claims. A federal judge is reviewing objections and is expected to decide on final approval in July 2026. Separately, the U.S. Supreme Court is expected to rule by late June 2026 on whether federal pesticide law blocks state failure-to-warn claims, a decision that could reshape future filings.

Eligible claimants generally include people who used Roundup regularly, such as farmers, landscapers, groundskeepers, golf course workers, and homeowners, and were later diagnosed with non-Hodgkin's lymphoma. Surviving family members of those who have died may also qualify.

Exposure history matters. Cases typically involve repeated use over months or years, not a single application. The more thorough the documentation of product, frequency, and time period, the stronger the claim. Statutes of limitations vary by state, so claimants should not delay an evaluation.